Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Mehmet Hilmi DOĞU"'
Autor:
Tahir Darcın, Istemi Serın, Mehmet Can Ugur, Omer Ekinci, İpek Yönal Hindilerden, Seval Akpınar, Tuba Hacıbekiroglu, Sinan Demircioğlu, Emine Gulturk, Murat Albayrak, İsmet Aydoğdu, Mehmet Sinan Dal, Mehmet Hilmi Doğu, Sinem Namdaroğlu, Ali Dogan, Meliha Nalçacı, Burhan Turgut, Semih Başcı, Fevzi Altuntaş
Publikováno v:
Hitit Medical Journal, Vol 6, Iss 2, Pp 186-192 (2024)
Objective: We present data of patients with relapsed/ refractory T cell lymphomas treated with brentuximab vedotin (BV) in real-world practice. Material and Method: This study is an observational, multi-center, retrospective study. The data of patien
Externí odkaz:
https://doaj.org/article/9ca01e30518240fc9f0619b73350c36a
Autor:
İstemi Serin, Mehmet Hilmi Doğu, Ömer Ekinci, Gülsüm Akgün Çağlıyan, Abdulkadir Baştürk, Merih Reis Aras, Sinan Demircioğlu, Burhan Turgut, Mustafa Merter, Sibel Kabukçu Hacıoğlu, Metin Bağcı, Murat Albayrak, Serdal Korkmaz, Mehmet Ali Erkurt, Mehmet Sinan Dal, Fadime Ersoy Dursun, Anıl Tombak, İsmet Aydoğdu, Turgay Ulaş, Fevzi Altuntaş
Publikováno v:
İstanbul Medical Journal, Vol 24, Iss 2, Pp 120-125 (2023)
Introduction:Ruxolitinib is a small -molecule inhibitor of the JAK1/2 pathway. This study aimed to reveal the results and side-effect profile of the use of ruxolitinib as a treatment option in polycythemia vera (PV).Methods:A total of 34 patients wit
Externí odkaz:
https://doaj.org/article/2f9813f1062246cfa7c5bb2a592ed5f8
Autor:
Ali İhsan GEMİCİ, İstemi SERİN, Vedat Buğra EROL, Mehmet Hilmi DOĞU, İdris İNCE, Rafet EREN, Atakan TEKİNALP, Volkan KARAKUŞ, İklil Nur KOÇ EROL, Zeynep Ece ARSLAN, Zekiye Nur TAY, Elif Nur TUNCER, Ömür Gökmen SEVİNDİK
Publikováno v:
Forbes Tıp Dergisi, Vol 3, Iss 2, Pp 165-172 (2022)
Objective: Both the length of the treatment period and the diversity of the agents used in the treatment significantly affect the quality of life (QoL) of the patients with multiple myeloma (MM). With the aid of the EORTC Quality of Life Questionnair
Externí odkaz:
https://doaj.org/article/72d32f8ee7ef496cb5937c20070d45bb
Autor:
Ömür Kayıkçı, Özgür Mehtap, İsmail Sarı, Fatih Demirkan, Cengiz Beyan, Güven Çetin, Filiz Vural, Mehmet Yılmaz, Erman Öztürk, Seval Akpınar, Bülent Eser, Mehmet Gündüz, Yahya Büyükaşık, Bahriye Payzin, Rahşan Yıldırım, Mehmet Hilmi Doğu, Atilla Özkan, Engin Kelkitli, Emre Tekgündüz
Publikováno v:
Turkish Journal of Hematology, Vol 39, Iss 3, Pp 170-177 (2022)
Objective: Peripheral T-cell lymphomas (PTCLs) are an uncommon and quite heterogeneous group of disorders, representing only 10%-15% of all non-Hodgkin lymphomas. Although both molecular and clinical studies have increased in recent years, we still h
Externí odkaz:
https://doaj.org/article/064de3f44cfb416da6444235fe3ba4b7
Autor:
Anıl Tombak, Funda Pepedil Tanrıkulu, Salih Sertaç Durusoy, Hüseyin Derya Dinçyürek, Emin Kaya, Elif Gülsüm Ümit, İrfan Yavaşoğlu, Özgür Mehtap, Burak Deveci, Mehmet Ali Özcan, Hatice Terzi, Müfide Okay, Nilgün Sayınalp, Mehmet Yılmaz, Vahap Okan, Alperen Kızıklı, Ömer Özcan, Güven Çetin, Sinan Demircioğlu, İsmet Aydoğdu, Güray Saydam, Eren Arslan Davulcu, Gül İlhan, Mehmet Ali Uçar, Gülsüm Özet, Seval Akpınar, Burhan Turgut, İlhami Berber, Erdal Kurtoğlu, Mehmet Sönmez, Derya Selim Batur, Rahşan Yıldırım, Vildan Özkocaman, Ahmet Kürşad Güneş, Birsen Sahip, Şehmus Ertop, Olga Meltem Akay, Abdülkadir Baştürk, Mehmet Hilmi Doğu, Aydan Akdeniz, Ali Ünal, Ahmet Seyhanlı, Emel Gürkan, Demet Çekdemir, Burhan Ferhanoğlu
Publikováno v:
Turkish Journal of Hematology, Vol 38, Iss 4, Pp 273-285 (2021)
Objective: This study aimed to retrospectively evaluate the efficacy, safety, and survival outcome of single-agent ibrutinib therapy in chronic lymphocytic leukemia patients. Materials and Methods: A total of 136 patients (mean age +- standard deviat
Externí odkaz:
https://doaj.org/article/506b9a34c2d64dd5beb096f766347808
Publikováno v:
İstanbul Medical Journal, Vol 22, Iss 4, Pp 245-249 (2021)
Introduction:Mucormycosis is an aggressive-progressive invasive fungal infection caused by mold fungi in the division of mucorales of the zygomycetes class with high mortality, and is the most common fungal infection in patients with hematologic mali
Externí odkaz:
https://doaj.org/article/0158689f9e3f41e4b56c2b3eabf5c4b3
Autor:
İstemi Serin, Mehmet Hilmi Doğu
Publikováno v:
İstanbul Medical Journal, Vol 22, Iss 1, Pp 73-77 (2021)
Introduction:Multiple myeloma (MM) constitutes approximately 10% of hematological malignan-cies with abnormal proliferation of plasma cells, which causes an abnormal increase of monoclonal immunoglobulin light chains. We aim to examine our young myel
Externí odkaz:
https://doaj.org/article/bf671b5620e64539ab3ae1e5aeead7af
Publikováno v:
İstanbul Medical Journal, Vol 21, Iss 6, Pp 473-476 (2020)
Introduction:Chronic myeloid leukaemia (CML) is a myeloproliferative neoplasm characterised by the overproduction of haematopoietic cells in the granulocytic series, involving translocation of chromosomes 9 and 22. The first tyrosine kinase inhibitor
Externí odkaz:
https://doaj.org/article/ac32087945d843eab59476c88efb164f
Publikováno v:
İstanbul Medical Journal, Vol 21, Iss 1, Pp 17-19 (2020)
Waldenström’s macroglobulinaemia is a disease in the B lymphoproliferative diseases group with immunoglobin M monoclonality and may present with different clinical manifestations. A 52-year-old male patient presented with complaints of weight loss
Externí odkaz:
https://doaj.org/article/74fab9843f2c48aab2b579656f48f806
Publikováno v:
İstanbul Medical Journal, Vol 21, Iss 1, Pp 23-25 (2020)
Fever of unknown origin (FUO) is defined as a fever ≥38.3 ºC on at least three occasions over a period of at least three weeks, with no obvious diagnosis despite one week of inpatient investigations. Over 200 infections, neoplasm and inflammatory
Externí odkaz:
https://doaj.org/article/8dd6e7904d4449448f908f66970c5312